ArticleAnnals of medicine2026

Adding anti-PD-1 antibody to definitive chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma: higher intensity does not equate to better outcomes.

Peiying Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.